肌肉发育不良的干预措施:分子药物进入诊所
Kate Bushby1, Hanns Lochmüller, Stephen Lynn
1Institute of Human Genetics, Newcastle University, Newcastle upon Tyne, UK. kate.bushby@ncl.ac.uk
Lancet (London, England)
|December 1, 2009
概括
肌肉发育不良是一种罕见的遗传疾病,导致慢性残疾. 虽然最终的疗法尚未确定,但诊断和管理方面的进步为受影响的人提供了更好的护理.
科学领域:
- 遗传学 是一个遗传学.
- 神经学 神经学
- 罕见疾病 罕见疾病
背景情况:
- 肌肉发育不良 (MDs) 是一组罕见的,遗传的神经肌肉疾病.
- 已经确定了超过30种不同的MD遗传亚型.
- 这些情况导致肌肉逐渐衰弱和退化,影响儿童和成人.
研究的目的:
- 审查肌肉发育不良症的诊断和管理方面的最新进展.
- 要突出正在进行的寻找最终的,基于病变的疗法.
- 讨论目前正在研究的新兴治疗策略.
主要方法:
- 对遗传分类和MD的诊断改进进行了审查.
- 分析当前的医疗管理策略.
- 对各种MD类型的临床前和临床治疗试验的调查.
主要成果:
- 在过去的二十年中,在定义MD的遗传亚型方面取得了重大进展.
- 在诊断,遗传咨询和临床管理方面提高了准确性.
- 包括基因和基于细胞的方法在内的各种潜在疗法正在开发中.
结论:
- 尽管没有确定的治疗方法,但在MD护理方面已经取得了实质性的改进.
- 对疾病机制的持续研究推动了新型治疗点的开发.
- 个性化医疗,途径调制,基因疗法和细胞疗法代表了MD治疗未来有希望的方向.
相关概念视频
Satellite Stem Cells and Muscular Dystrophy
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...


